Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2012
05/03/2012WO2012055904A1 Temperature-stable ss-pyranosidase
05/03/2012WO2012055596A1 Extracellular matrices which can be used as scaffold for living cells
05/03/2012WO2012055554A1 Rapid method for targeted cell (line) selection
05/03/2012WO2012055551A2 Nf-kb signal path-manipulated dendritic cells
05/03/2012WO2012055541A1 Tgf-beta in the development of conventional dendritic cells and uses thereof
05/03/2012WO2012031263A3 Cell culture system for bioreactor scale-up of cells
05/03/2012WO2012025914A8 Induced pluripotent stem cells derived from human pancreatic beta cells
05/03/2012WO2012019122A3 Simplified basic media for human pluripotent cell culture
05/03/2012WO2012019002A3 Somatic stem cells
05/03/2012WO2012012737A3 Stable tregs and related materials and methods
05/03/2012WO2012008813A3 Culture medium composition for culturing amnion-derived mesenchymal stem cell, and method for culturing amnion-derived mesenchymal stem cell by using same
05/03/2012WO2011159050A3 Method for differentiating human neural progenitor cells into dopaminergic neurons, and medium for differentiation thereof
05/03/2012WO2011139132A3 Method for the mass proliferation of embryoid bodies produced from stem cells, and for maintaining the embryoid bodies
05/03/2012WO2011060342A8 Cardiac differentiation of human pluripotent stem cells under defined conditions using matrix overlay methods
05/03/2012US20120110706 Modified bacillus thuringiensis cry21 proteins for nematode control
05/03/2012US20120110700 Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (llrk) polypeptides and homologs thereof
05/03/2012US20120110699 Method for promoting the formation of secondary cell wall of plant
05/03/2012US20120110694 Plant myb transcription factor homologs
05/03/2012US20120110692 Cotton variety 99m-548
05/03/2012US20120110691 Cotton variety p07x.8244.rf
05/03/2012US20120110690 Cotton variety p07x.8212.rf
05/03/2012US20120110689 Cotton variety p07x.8213.rf
05/03/2012US20120110688 Aad-12 event 1606 and related transgenic soybean lines
05/03/2012US20120110687 Pepper hybrid ps 16351609
05/03/2012US20120110686 Cand45 tRNA-Derived Expression System for Gene Modulation
05/03/2012US20120110685 Modular dna-binding domains and methods of use
05/03/2012US20120110682 Animal Model for Toxicology and Dose Prediction
05/03/2012US20120109107 Muscle Derived Cells for the Treatment of Urinary Tract Pathologies and Methods of Making and Using the Same
05/03/2012US20120108880 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
05/03/2012US20120108795 Antibodies Binding Human Collagen II
05/03/2012US20120108790 Truncated Somatostatin Receptors
05/03/2012US20120108666 Treatment of Cell Proliferative Disorders
05/03/2012US20120108662 Compositions and methods for treating skin disorders
05/03/2012US20120108657 Disease-associated protein
05/03/2012US20120108646 RNAi Modulation Of TGF-BETA And Therapeutic Uses Thereof
05/03/2012US20120108630 Hedgehog Pathway Antagonists and Methods of Use
05/03/2012US20120108606 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same
05/03/2012US20120108605 O-glcnac transferase inhibitors and uses thereof
05/03/2012US20120108581 Fused piperidine compound and pharmaceutical containing same
05/03/2012US20120108566 Nicotinamides as jak kinase modulators
05/03/2012US20120108523 Disease-associated protein
05/03/2012US20120108521 Immunostimulatory compositions and uses thereof
05/03/2012US20120108507 Methods for In Vivo Cell Reprogramming
05/03/2012US20120108500 Compositions and Methods for Modulating Immunodeficiency Virus Transcription
05/03/2012US20120108493 Polypeptide Fragments Comprising Endonuclease Activity and Their Use
05/03/2012US20120108464 Test systems, methods and uses involving as160 protein
05/03/2012US20120107939 Down-regulation of gene expression using artificial micrornas
05/03/2012US20120107937 Mitochondrial enhancement of cells
05/03/2012US20120107936 Cultured pancreas islets
05/03/2012US20120107935 Simplicity in assembling microstructures
05/03/2012US20120107934 Human Late Stage Motor Neuron Progenitor Cells and Methods of Making and Using Same
05/03/2012US20120107933 Anti-mesothelin antibodies
05/03/2012US20120107932 Prrs-virus receptor and its inhibitor
05/03/2012US20120107931 Differentiation of primate pluripotent stem cells to hematopoietic lineage cells
05/03/2012US20120107930 Method for inducing differentiation of embryonic stem cells or artificial pluripotent stem cells
05/03/2012US20120107929 Variable Lymphocyte Receptors, Related Polypeptides and Nucleic Acids, and Uses Thereof
05/03/2012US20120107928 Antibody Inhibitors of GDF-8 and Uses Thereof
05/03/2012US20120107927 Methods and devices for isolating embryonic stem cells
05/03/2012US20120107926 Apparatus for cell or tissue culture
05/03/2012US20120107925 Devices for separating cells and methods of using them
05/03/2012US20120107924 Compositions and methods for modifying cell surface glycans
05/03/2012US20120107912 Cell lysis device and methods of lysing cells or viruses
05/03/2012US20120107898 Method for obtaining human microglial precursor cells from pluripotent stem cells
05/03/2012US20120107897 Double-stranded oligonucleotides
05/03/2012US20120107868 Processes for making protein hydrolysates from animal peptone and for preserving mucosa
05/03/2012US20120107863 Modulation of telomere length in telomerase positive cells and cancer therapy
05/03/2012US20120107833 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
05/03/2012US20120107828 Method for identifying a subpopulation of mammalian cells with distinctive ribosome translation profiles
05/03/2012US20120107827 PSMCs As Modifiers of the RB Pathway and Methods of Use
05/03/2012US20120107458 Spinach line sp6111
05/03/2012US20120107452 Aeration systems for horizontal photobioreactors
05/03/2012US20120107413 Pre-natal mesenchymal stem cells
05/03/2012US20120107389 Amphoteric liposomal compositions for cellular delivery of small rna molecules for use in rna interference
05/03/2012US20120107372 Recombinant gelatins
05/03/2012US20120107364 Antibody having anti-cancer activity
05/03/2012US20120107357 Novel divergent picornavirus: cosavirus
05/03/2012US20120107350 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof
05/03/2012US20120107342 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
05/03/2012US20120107339 Chimeric Factor H Binding Proteins (fHBP) Containing a Heterologous B Domain and Methods of Use
05/03/2012US20120107336 Modified defensins and their use
05/03/2012US20120107333 Vangl1 peptides and vaccines including the same
05/03/2012US20120107330 Antagonists, uses & methods for partially inhibiting tnfr1
05/03/2012US20120107325 IL-17 Antagonistic Antibodies
05/03/2012US20120107324 TARGETED BINDING AGENTS DIRECTED TO a5ß1 AND USES THEREOF
05/03/2012US20120107321 Antibodies And Epitopes Specific To Misfolded Prion Protein
05/03/2012US20120107319 Pharmaceutical compositions comprising antibodies binding to the intracellular domain of EBV (Epstein-Barr virus) latent membrane protein-1 (LMP1)
05/03/2012US20120107299 Phosphorylation-inhibiting agent or dephosphorylating agent for pten
05/03/2012US20120107292 METHOD FOR THE SIMULTANEOUS INDUCTION OF CTL AND gamma-delta T CELL
05/03/2012US20120107286 Pluripotent stem cells
05/03/2012US20120107285 Mitochondrial enhancement of cells
05/03/2012US20120107283 Human skin equivalents expressing exogenous polypeptides
05/03/2012US20120107281 Compositions and methods for modifying cell surface glycans
05/03/2012US20120107265 Method for producing monoterpene and monoterpinoid compounds and use thereof
05/03/2012US20120107264 Nucleic acid delivery compounds
05/03/2012US20120107247 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and their Use as Diagnostic Reagents and Vaccines
05/03/2012US20120107244 MONOMERIC VARIANTS OF THE TETRAMERIC eqFP611
05/03/2012US20120107242 Nucleic acid-mediated shape control of nanoparticles for biomedical applications
05/03/2012US20120107234 Pan-HER Antibody Composition
05/03/2012DE102010050460A1 Chondrone zur Knorpeltherapie Chondrones cartilage therapy
05/03/2012CA2816291A1 Novel anti-dr5 antibody
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 1827